LGL Partners’s Opko Health OPK Stock Holding History

LGL Partners’s Portfolio OPK Stock Details OPK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-44,507	Closed	-$50.7K	–	70
2026 Q1	$50.7K	Buy	+44,507	New	+$54.8K	0.02%	66
2017 Q3	–	Sell	-47,507	Closed	-$313K	–	79
2017 Q2	$313K	Hold	47,507	–	–	0.17%	69
2017 Q1	$380K	Hold	47,507	–	–	0.19%	59
2016 Q4	$442K	Hold	47,507	–	–	0.24%	51
2016 Q3	$508K	Sell	47,507 -4,000	-8%	-$39.8K	0.27%	45
2016 Q2	$508K	Sell	51,507 -2,000	-4%	-$20.3K	0.28%	46
2016 Q1	$556K	Buy	+53,507	New	+$489K	0.29%	48

Other funds holding OPK

RCMNY

Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

WCM

Whitefort Capital Management New York $406M AUM 84.26% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

LGL Partners's OPK Position: Q2 2026 in Review

LGL Partners sold out of Opko Health (OPK) in Q2 2026, closing a stake of 44,507 shares — an estimated $50.7K sold.

LGL Partners first reported a position in OPK in Q1 2016 and held it in 7 quarters. The position peaked at $556K in Q1 2016. 223 funds tracked by Wall St. Rank hold OPK as of Q2 2026.

LGL Partners reported no remaining Opko Health position as of Q2 2026 after selling out during the quarter.
LGL Partners sold 44,507 Opko Health shares in Q2 2026, an estimated $50.7K.
LGL Partners first reported a position in Opko Health in Q1 2016 and held it in 7 quarters.
LGL Partners's Opko Health position peaked at $556K in Q1 2016.
223 funds tracked by Wall St. Rank held Opko Health as of Q2 2026.

Based on LGL Partners's 13F filing for Q2 2026, filed 27 Jul 2026.